Gene-BIT Life Sciences' third annual world congress. Anti-neurodegenerative and anti-inflammation biotherapeutics.
The BIT Life Sciences' Third Annual World Congress of Gene, held in Sanshui, China, included topics covering new developments in the field of gene-based therapeutic approaches and target identification. This conference report highlights selected presentations on aspirin-triggered lipoxins for inflammation, hepatocyte nuclear factor HNF4alpha as a target for intestinal inflammation, P2Y nucleotide receptor antagonism for inflammatory diseases, antioxidant approaches for hearing loss prevention, targeting protein kinase CK2 in neuronal injury, the role of AATF (apoptosis antagonizing transcription factor)-mediated neuroprotection in Alzheimer's disease, and lessons from bioactive proteins from plants.
Filep
Janos G
JG
University of Montréal, Maisonneuve-Rosemont Hospital Research Centre, 5415 Boulevard de l'Assomption, Montréal, QC H1T 2M4, Canada. janos.g.filep@umontreal.ca
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D016503:Drug Delivery Systems; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D018696:Neuroprotective Agents